<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01838759</url>
  </required_header>
  <id_info>
    <org_study_id>BEUN 2013-31-26/02</org_study_id>
    <nct_id>NCT01838759</nct_id>
  </id_info>
  <brief_title>Bioimpedance Spectroscopy for the Differential Diagnosis of Hyponatremia</brief_title>
  <official_title>Bioimpedance Spectroscopy for the Differential Diagnosis of Hyponatremia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zonguldak Karaelmas University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zonguldak Karaelmas University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aimed to investigate the role of bioimpedance spectroscopy for the diagnosis of
      hyponatremia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Up to now, &quot;Hyponatremia&quot; differentially diagnosed by physical examination, plasma and
           urine osmolalities, Echocardiography and biochemical measurements.

        -  The purpose of this study is to determine whether bioimpedance spectroscopy can be used
           for the detection of hypovolemia and hypervolemia for the differential diagnosis of
           hyponatremia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Accuracy of volume status measured by bioimpedance spectroscopy</measure>
    <time_frame>Six months</time_frame>
    <description>BIOIMPEDANCE SPECTROSCOPY:
Overhydration (OH) measurement by Body Composition Monitor (Fresenius Medical Care)
Negative values of &quot;OH&quot; indicating Hypovolemia and positive values for hypervolemia in hyponatremic patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Laboratory data and echocardiography</measure>
    <time_frame>6 Months</time_frame>
    <description>LABORATORY MEASUREMENTS Hemoglobin, Hematocrit, White blood cell count Platelet count, Na, Potassium, Chlorur, Urea, Creatinine, Uric acid, Plasma osmolality, Urine osmolality, Alanine transaminase , Aspartate transaminase , Urine specific gravity,
TREATMENT MODALITY
Diuretics
Intravenous hydration by isotonic saline
ECHOCARDIOGRAPHY:
Left ventricular end-diastolic diameter, Left ventricular end-systolic diameter, Ejection fraction(%), Left Atrium diameter, Aortic diameter, Right atrium diameter, Interventricular septum, Posterior wall thickness, Mitral insufficiency, Pulmonary insufficiency, Systolic pulmonary artery pressure, Tricuspid insufficiency</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">58</enrollment>
  <condition>Hyponatremia</condition>
  <arm_group>
    <arm_group_label>Hypovolemic hyponatremia</arm_group_label>
    <description>Negative values of &quot;Overhydration&quot; measured by Bioimpedance spectroscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypervolemic hyponatremia</arm_group_label>
    <description>Positive values of &quot;Overhydration&quot; measured by Bioimpedance spectroscopy</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to Bulent Ecevit University Hospital with the presentation of
        hyponatremia
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Willing to participate in the study with written informed consent

          -  Older than 18-years

        Exclusion Criteria:

          -  The presence of pacemaker or defibrillator

          -  Artificial joints, pin or amputation

          -  Pregnancy or lactating.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ender Hur, Assoc.Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Bulent Ecevit University Medical School, Division of Nephrology, Zonguldak, Turkey</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bulent Ecevit University Hospital</name>
      <address>
        <city>Zonguldak</city>
        <zip>67300</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Hur E, Usta M, Toz H, Asci G, Wabel P, Kahvecioglu S, Kayikcioglu M, Demirci MS, Ozkahya M, Duman S, Ok E. Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis. 2013 Jun;61(6):957-65. doi: 10.1053/j.ajkd.2012.12.017. Epub 2013 Feb 15.</citation>
    <PMID>23415416</PMID>
  </reference>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2013</study_first_submitted>
  <study_first_submitted_qc>April 20, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 24, 2013</study_first_posted>
  <last_update_submitted>October 30, 2014</last_update_submitted>
  <last_update_submitted_qc>October 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zonguldak Karaelmas University</investigator_affiliation>
    <investigator_full_name>Ender Hur</investigator_full_name>
    <investigator_title>Associate Professor Doctor</investigator_title>
  </responsible_party>
  <keyword>Bioimpedance spectroscopy</keyword>
  <keyword>Hypervolemia</keyword>
  <keyword>Hypovolemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyponatremia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

